Common use of Strategy 2: Induction onto Medications and Coordinated Treatment Clause in Contracts

Strategy 2: Induction onto Medications and Coordinated Treatment. A person that survives an opioid overdose with the use of opioid overdose reversal medications immediately experiences withdrawal symptoms. Untreated symptoms often result in a recurrence to use of opioids leaving the person vulnerable to a fatal overdose. Symptoms of withdrawal can be managed with FDA-approved medications used to treat opioid use disorder. This strategy provides induction onto medications used to treat opioid use disorder and links the person with ongoing treatment services. Performing Agency will: 1. Designate prescriber(s) of buprenorphine for the treatment of Opioid Use Disorder (OUD), and to ensure the designated provider(s) prescribing physician, nurse practitioners, and/or physician assistants participate in DATA 2000 Waiver Training and obtain the waiver to prescribe provide buprenorphine for the treatment of opioid use disorder for each designated prescriber within 30 days of project start date.